Periodic Reporting for period 1 - OSTEOMET (Clinical Validation of a Novel Biomarker for the Prediction of Bone Metastasis in Early Stage Breast and Prostate Cancer)

Overall Business Innovation Project ObjectivesOur overall goal is to introduce a new in vitro diagnostic device (IVDD), named OSTEOMET, in the market as a treatment guide to identify breast and prostate cancer patients who, according to their risk of developing bone...